CA Stock MarketDetailed Quotes
CSCI Cosciens Biopharma Inc
- 4.210
- +0.010+0.24%
15min DelayMarket Closed Nov 29 16:00 ET
13.15MMarket Cap-698P/E (TTM)
4.450High4.150Low1.93KVolume4.150Open4.200Pre Close8.18KTurnover9.00052wk High0.07%Turnover Ratio3.12MShares3.78052wk Low-6.027EPS TTM12.02MFloat Cap9.000Historical HighLossP/E (Static)2.85MShs Float3.780Historical Low-2.541EPS LYR7.14%Amplitude--Dividend TTM0.47P/B1Lot Size--Div YieldTTM
Cosciens Biopharma Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -5,502.08%-7.78M | -70.85%-1.39M | -189.11%-2.4M | -155.85%-2.73M | -261.74%-1.23M | -86.36%144K | -140.04%-813K | -179.61%-828.98K | 77.61%4.89M | 44.21%762.98K |
| Net income from continuing operations | -641.62%-5.76M | -65.35%-1.42M | -391.40%-1.4M | -209.56%-3.55M | -1,032.67%-1.63M | -234.59%-776K | -163.44%-860K | -119.60%-284.67K | 22.77%3.24M | -114.11%-143.85K |
| Operating gains losses | ---136K | ---1.71M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 31.96%479K | 4.14%377K | -0.08%358.46K | 4.21%1.47M | 2.73%383.49K | 18.61%363K | 0.99%362K | -3.15%358.76K | -4.53%1.41M | 0.65%373.31K |
| Asset impairment expenditure | --1.46M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Remuneration paid in stock | 1,193.94%427K | -69.77%13K | -85.52%14.36K | 195.58%195.24K | 51.15%19.24K | 47.71%33K | 125.86%43K | 729.82%99.13K | 370.34%66.05K | 282.82%12.73K |
| Deferred tax | 47.17%-112K | -101.70%-474K | -428.39%-411.54K | -188.65%-900.61K | -1,105.28%-375.61K | -218.85%-212K | -156.03%-235K | -117.34%-77.89K | 557.96%1.02M | 85.95%-31.16K |
| Other non cashItems | ---16K | --11K | -12.87%21.77K | 0.86%96.59K | ---- | ---- | ---- | -5.56%24.99K | -19.62%95.76K | -13.40%25.13K |
| Change In working capital | -660.46%-4.13M | 1,578.05%1.82M | -3.76%-959.03K | 106.80%57.21K | -33.29%368.21K | 2,728.44%736K | -0.51%-123K | 25.60%-924.31K | 27.43%-840.84K | 185.56%551.95K |
| -Change in receivables | -327.97%-978K | -56.74%427K | -1,762.64%-1.11M | 390.70%1.79M | 5,383.35%431.84K | 8.35%429K | 498.56%987K | 94.97%-59.55K | -346.36%-615K | -97.81%7.88K |
| -Change in inventory | -21.89%-206K | 174.44%501K | 208.67%392.46K | -10.80%-1.17M | 109.29%33.13K | 54.91%-169K | -54.23%-673K | -422.90%-361.13K | -20.84%-1.06M | 42.61%-356.47K |
| -Change in prepaid assets | 424.39%266K | 621.57%368K | -370.95%-119.76K | -680.99%-130.01K | -569.52%-74.01K | -778.08%-82K | -50.43%51K | 76.53%-25.43K | -74.31%22.38K | 175.79%15.76K |
| -Change in payables and accrued expense | -739.07%-3.57M | 215.78%565K | 74.38%-122.49K | -153.34%-430.75K | -102.57%-22.75K | 1,011.59%558K | -1,156.51%-488K | -669.26%-478.19K | 444.65%807.6K | 344.33%884.78K |
| -Change in other working capital | --359K | ---43K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Interest paid (cash flow from operating activities) | ---- | ---- | 12.87%-21.77K | -0.86%-96.59K | ---- | ---- | ---- | 5.56%-24.99K | 12.96%-95.76K | 5.54%-25.13K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -5,502.08%-7.78M | -70.85%-1.39M | -189.11%-2.4M | -155.85%-2.73M | -261.74%-1.23M | -86.36%144K | -140.04%-813K | -179.61%-828.98K | 77.61%4.89M | 44.21%762.98K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 266.00%83K | 48,025.93%25.88M | -1,711.84%-563.43K | -158.05%-739.28K | -4,623.20%-604.28K | 0.75%-50K | -34.43%-54K | 83.02%-31.1K | 53.80%-286.49K | 89.03%-12.79K |
| Net PPE purchase and sale | -162.00%-131K | -190.74%-157K | -1,711.84%-563.43K | -158.05%-739.28K | -1,166.51%-604.28K | 4.80%-50K | -30.56%-54K | 78.54%-31.1K | 48.11%-286.49K | 68.77%-47.71K |
| Net business purchase and sale | --0 | --26.04M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net other investing changes | --214K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 266.00%83K | 48,025.93%25.88M | -1,711.84%-563.43K | -158.05%-739.28K | -4,623.20%-604.28K | 0.75%-50K | -34.43%-54K | 83.02%-31.1K | 53.80%-286.49K | 89.03%-12.79K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -218.64%-188K | -80.00%-126K | -15.56%-71.92K | -70.76%-274.05K | -42.24%-82.05K | -54.10%-59K | -801.90%-70K | -9.66%-62.24K | 33.52%-160.49K | 52.34%-57.69K |
| Net issuance payments of debt | -60.56%-114K | -80.00%-126K | -12.87%-71.92K | -26.71%-279.26K | -19.25%-74.26K | -51.36%-71K | -29.24%-70K | -11.70%-63.72K | 16.01%-220.39K | 48.55%-62.27K |
| Proceeds from stock option exercised by employees | -716.67%-74K | --0 | --0 | -78.73%12.74K | -105.68%-260.6664 | 39.20%12K | --0 | 412.78%1.48K | 185.75%59.9K | 54,620.91%4.59K |
| Net other financing activities | ---- | ---- | ---- | ---7.54K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -218.64%-188K | -80.00%-126K | -15.56%-71.92K | -70.76%-274.05K | -42.24%-82.05K | -54.10%-59K | -801.90%-70K | -9.66%-62.24K | 33.52%-160.49K | 52.34%-57.69K |
| Net cash flow | ||||||||||
| Beginning cash position | 225.65%27.8M | -62.28%3.51M | -35.90%6.55M | 81.59%10.41M | -11.40%8.36M | -3.22%8.54M | 32.15%9.3M | 63.83%10.21M | 36.15%5.73M | 62.49%9.44M |
| Current changes in cash | -22,625.71%-7.88M | 2,700.32%24.37M | -228.74%-3.03M | -184.28%-3.74M | -377.31%-1.92M | -96.38%35K | -147.27%-937K | -215.08%-922.32K | 134.87%4.44M | 137.61%692.5K |
| Effect of exchange rate changes | 137.32%78K | -137.22%-67K | ---- | ---- | ---- | ---209K | --180K | ---- | ---- | ---- |
| End cash Position | 139.10%20M | 225.65%27.8M | -62.18%3.51M | -34.49%6.67M | -34.49%6.67M | -11.40%8.36M | -3.22%8.54M | 32.05%9.29M | 66.75%10.18M | 66.75%10.18M |
| Free cash from | -8,514.89%-7.91M | -78.32%-1.55M | -244.16%-2.96M | -175.38%-3.47M | -357.01%-1.84M | -90.63%94K | -143.59%-867K | -195.94%-860.08K | 109.51%4.6M | 90.09%715.26K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data